EMA to review teriflunomide

EMA accepted for review an MAA from Sanofi (Euronext:SAN; NYSE:SNY) for teriflunomide to treat relapsing forms of multiple sclerosis (MS). The dihydroorotate dehydrogenase (DHODH) inhibitor is under r...